OIG Accelerated Approval Report Spotlights Financial Costs Ahead Of Congressional Debate

 
• By Sarah Karlin-Smith
  
spotlight
New OIG accelerated approval report could impact chances of Congressional reform this year. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership